The post INJ Price Prediction: Target $5.20-5.80 by January 2026 Based on Emerging Bullish Momentum appeared on BitcoinEthereumNews.com. Joerg Hiller Dec 30,The post INJ Price Prediction: Target $5.20-5.80 by January 2026 Based on Emerging Bullish Momentum appeared on BitcoinEthereumNews.com. Joerg Hiller Dec 30,

INJ Price Prediction: Target $5.20-5.80 by January 2026 Based on Emerging Bullish Momentum



Joerg Hiller
Dec 30, 2025 15:47

INJ price prediction shows potential recovery to $5.20-5.80 range within 4-6 weeks as MACD histogram turns positive and RSI rebounds from oversold conditions.

INJ Price Prediction Summary

INJ short-term target (1 week): $4.85-4.95 (+6-8% from current $4.58)
Injective medium-term forecast (1 month): $5.20-5.80 range (+14-27% upside potential)
Key level to break for bullish continuation: $5.80 (immediate resistance)
Critical support if bearish: $4.35 (strong support coinciding with immediate support level)

Recent Injective Price Predictions from Analysts

The latest INJ price prediction data reveals a cautiously optimistic consensus among analysts. CoinCodex has consistently maintained targets between $4.69-$4.77 over the past three days, representing modest upside from current levels. Their most recent Injective forecast of $4.77 suggests a 4.1% increase from the current $4.58 price.

More bullish is Coinbase’s long-term INJ price target of $6.14, projecting a 34% gain from current levels over a five-year horizon. This aligns with a 5% annual growth assumption and suggests institutional confidence in Injective’s long-term prospects.

The European analysis from Finst provides a more conservative Injective forecast of €4.015 (approximately $4.20 USD), which appears overly pessimistic given current technical momentum. This creates an interesting divergence where European analysts are more bearish than their US counterparts.

INJ Technical Analysis: Setting Up for Recovery

The Injective technical analysis reveals several encouraging signals for a potential price recovery. The MACD histogram has turned positive at 0.0500, indicating that bearish momentum is waning and bulls are beginning to regain control. This is particularly significant given that INJ has been in a downtrend since hitting its 52-week high of $16.21.

The RSI at 39.59 sits in neutral territory but closer to oversold conditions, suggesting limited downside risk. When combined with the positive MACD histogram, this creates a favorable setup for a bounce. The Bollinger Bands position of 0.32 indicates INJ is trading in the lower half of its recent range, providing room for upward movement toward the middle band at $4.81.

Volume analysis shows $2.94 million in 24-hour trading on Binance, which is moderate but sufficient to support a meaningful price move if momentum builds. The daily ATR of $0.35 suggests normal volatility levels, making the predicted price movements technically achievable.

Injective Price Targets: Bull and Bear Scenarios

Bullish Case for INJ

The primary INJ price target in a bullish scenario is the $5.20-5.80 range, representing the area between the 50-day SMA ($5.55) and immediate resistance ($5.80). For this scenario to unfold, INJ needs to first break above the 20-day SMA at $4.81, which would signal that the recent downtrend is reversing.

A successful break above $5.80 could trigger a more aggressive rally toward $6.14, aligning with Coinbase’s long-term target. The technical setup supports this possibility, as the positive MACD histogram suggests underlying strength is building.

Bearish Risk for Injective

The key risk level to monitor is the $4.35 support zone, which represents both immediate and strong support according to the technical data. A break below this level could trigger a decline toward the 52-week low of $4.43, representing limited additional downside.

However, given the current RSI level and positive MACD momentum, a break below $4.35 appears unlikely in the near term unless broader market conditions deteriorate significantly.

Should You Buy INJ Now? Entry Strategy

Based on the current Injective technical analysis, the answer to “buy or sell INJ” leans toward a cautious buy for traders with appropriate risk management. The optimal entry strategy involves:

Primary Entry Zone: $4.50-4.60 (current levels offer good risk-reward)
Stop-Loss Level: $4.30 (below critical support at $4.35)
First Target: $4.85-4.95 (20-day SMA area)
Second Target: $5.20-5.80 (medium-term INJ price target)

Position sizing should be conservative given the 71% decline from the 52-week high. Consider allocating no more than 2-3% of portfolio value to this trade, as crypto markets remain volatile.

INJ Price Prediction Conclusion

The INJ price prediction for the next 4-6 weeks targets the $5.20-5.80 range, representing a 14-27% upside potential from current levels. This Injective forecast is supported by emerging bullish momentum indicators, particularly the positive MACD histogram and oversold RSI conditions.

Confidence Level: MEDIUM-HIGH for the short-term target of $4.85-4.95, and MEDIUM for the extended target of $5.20-5.80.

Key indicators to watch for confirmation include a break above the 20-day SMA at $4.81 and sustained RSI movement above 45. Invalidation signals would include a break below $4.35 support with high volume. The timeline for this prediction is 4-6 weeks, with initial movement expected within the next 7-10 days as the positive MACD momentum builds.

Image source: Shutterstock

Source: https://blockchain.news/news/20251230-price-prediction-target-inj-520-580-by-january-2026-based

Market Opportunity
Injective Logo
Injective Price(INJ)
$4.48
$4.48$4.48
-2.56%
USD
Injective (INJ) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

US Opposes DeFi Fund’s Brief in Ethereum MEV Case Retrial Review

US Opposes DeFi Fund’s Brief in Ethereum MEV Case Retrial Review

The post US Opposes DeFi Fund’s Brief in Ethereum MEV Case Retrial Review appeared on BitcoinEthereumNews.com. The US government opposed the DeFi Education Fund
Share
BitcoinEthereumNews2025/12/31 10:22
Vitalik: Crypto projects should prioritize a decentralized model to avoid excessive concentration of power and related risks.

Vitalik: Crypto projects should prioritize a decentralized model to avoid excessive concentration of power and related risks.

On December 31st, PANews reported that Ethereum co-founder Vitalik Buterin published an article titled "Balance of Power," exploring the relationship between power
Share
PANews2025/12/31 10:21
Chorus One and MEV Zone Team Up to Boost Avalanche Staking Rewards

Chorus One and MEV Zone Team Up to Boost Avalanche Staking Rewards

The post Chorus One and MEV Zone Team Up to Boost Avalanche Staking Rewards appeared on BitcoinEthereumNews.com. Through the partnership with MEV Zone, Chorus One users will earn extra yield automatically. The Chorus One Avalanche node has a total stake of over 1.7 million, valued at around $55 million. This collaboration will introduce MEV Zone to both public nodes and Validator-as-a-Service. The Avalanche network stands to benefit from fairer and more efficient markets due to enhanced transparency. Chorus One, a highly decorated institutional-grade staking provider, has inked a strategic partnership with MEV Zone to enhance yield generation on the Avalanche (AVAX) network. The Chorus One partnered with MEV Zone to increase the AVAX staking yields, while simultaneously contributing to the general growth of the Avalanche network. “At Chorus One, we see this as an important step in our ongoing journey to provide robust infrastructure and innovative yield strategies for our partners and clients,” the announcement noted.  Why Did Chorus One Partner With MEV Zone? The Chorus One platform has grown to a top-tier institutional-grade staking ecosystem, with more than 40 blockchains, since 2018. In a bid to evolve with the needs of crypto investors and the supported blockchains, Chorus One has inked several strategic partnerships in the recent past, including MEV Zone. In the recent past, MEV Zone has specialized in addressing the Maximal Extractable Value (MEV) challenges on the Avalanche network. The MEV Zone will help Chorus One’s AVAX node validator to use Proposer-Builder Separation (PBS). As such, Chorus One’s AVAX node will seamlessly select certain transactions that are more profitable when making blocks. For instance, MEV Zone will help Chorus One’s AVAX node validator to capture arbitrage and liquidation transactions more often since they are more profitable.  How will Chorus One’s AVAX Stakers Benefit Via This Partnership? The Chorus One AVAX node has grown over the years to more than 1.77 million coins staked, valued…
Share
BitcoinEthereumNews2025/09/18 03:19